Spinocerebellar ataxias: an update
- 1 August 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 20 (4), 438-446
- https://doi.org/10.1097/wco.0b013e3281fbd3dd
Abstract
Here we discuss recent advances regarding the molecular genetic basis of dominantly inherited ataxias.Important recent observations include insights into the mechanisms by which expanded polyglutamine causes cerebellar degeneration; new findings regarding how noncoding expansions may cause disease; the discovery that conventional (i.e. nonrepeat) mutations underlie recently identified ataxias; and growing recognition that multiple biological pathways, when perturbed, can cause cerebellar degeneration.The dominant ataxias, also known as spinocerebellar ataxias, continue to grow in number. Here we review the major categories of spinocerebellar ataxias: expanded polyglutamine ataxias; noncoding repeat ataxias; and ataxias caused by conventional mutations. After discussing features shared by these disorders, we present recent evidence supporting a toxic protein mechanism for the polyglutamine spinocerebellar ataxias and the recognition that both protein misfolding and perturbations in nuclear events represent key events in pathogenesis. Less is known about pathogenic mechanisms in spinocerebellar ataxias due to noncoding repeats, though a toxic RNA effect remains possible. Newly discovered, conventional mutations in spinocerebellar ataxias suggest a wide range of biological pathways can be disrupted to cause progressive ataxia. Finally, we discuss how new mechanistic insights can drive the push toward preventive treatment.Keywords
This publication has 58 references indexed in Scilit:
- A toxic monomeric conformer of the polyglutamine proteinNature Structural & Molecular Biology, 2007
- Brain CHIP: removing the culprits in neurodegenerative diseaseTrends in Molecular Medicine, 2007
- The Interplay between PolyQ and Protein Context Delays Aggregation by Forming a Reservoir of ProtofibrilsPLOS ONE, 2006
- RNA-dominant diseasesHuman Molecular Genetics, 2006
- CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and DegradationJournal of Biological Chemistry, 2006
- Chaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic OligomersMolecular Cell, 2006
- RNA-MEDIATED NEUROMUSCULAR DISORDERSAnnual Review of Neuroscience, 2006
- Molecular pathogenesis of spinocerebellar ataxiasBrain, 2006
- Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine DiseasesScience, 2006
- CHIP Suppresses Polyglutamine Aggregation and ToxicityIn VitroandIn VivoJournal of Neuroscience, 2005